Hip and back arthritis who to see and whenHip replacement is usually considered when pain and stiffness dominate daily life despite exercise, medication and physiotherapy, rather than when a single score or scan reaches a set threshold. Persistent groin pain, stiffness lasting 30 minutes or less, or mixed hip and back symptoms usually start with a GP or…Hip replacement is usually considered when pain and stiffness dominate daily life despite exercise, medication and physiotherapy, rather than when a single score or scan reaches a set threshold. Persistent groin pain, stiffness lasting 30 minutes or less, or mixed hip and back symptoms usually start with a GP or NHS MSK assessment, with rheumatology, orthopaedics or pain services added as needed.
Choosing advanced injection options for knee osteoarthritisArthrosamid, a 2.5% polyacrylamide hydrogel given as a single 6 mL knee injection, is designed to stay in the joint and has extension data showing WOMAC pain improvements maintained to five years. MFAT, PRP and BMAC offer biologic alternatives, but their evidence is smaller and less consistent.Arthrosamid, a 2.5% polyacrylamide hydrogel given as a single 6 mL knee injection, is designed to stay in the joint and has extension data showing WOMAC pain improvements maintained to five years. MFAT, PRP and BMAC offer biologic alternatives, but their evidence is smaller and less consistent.
Evaluating newer joint injections against repeat steroid shotsRepeat corticosteroid injections for hip and knee pain ease symptoms for about six weeks, then lose effect, while frequent use can accelerate cartilage loss. Exosomes for knee osteoarthritis remain unapproved and experimental, and BMAC for ankle cartilage defects is usually an adjunct with limited trial evidence.Repeat corticosteroid injections for hip and knee pain ease symptoms for about six weeks, then lose effect, while frequent use can accelerate cartilage loss. Exosomes for knee osteoarthritis remain unapproved and experimental, and BMAC for ankle cartilage defects is usually an adjunct with limited trial evidence.
Deciding on return to running and frozen shoulder careReturn to running after an ankle sprain is judged by pain, swelling, movement, strength, balance and confidence, not by a fixed number of days. Frozen shoulder is usually a gradual, painful loss of active and passive movement, most often in adults aged 40 to 60 and linked to diabetes and…Return to running after an ankle sprain is judged by pain, swelling, movement, strength, balance and confidence, not by a fixed number of days. Frozen shoulder is usually a gradual, painful loss of active and passive movement, most often in adults aged 40 to 60 and linked to diabetes and thyroid disease.
Choosing joint preserving surgery before knee replacementOne-compartment knee wear does not automatically mean replacement is next: bracing, osteotomy and focal cartilage repair can reduce pain and delay arthroplasty when alignment and damage remain localised. Microfracture is now usually limited to very small defects, while AMIC, MACI, OATS and OCA are chosen by lesion size, depth and…One-compartment knee wear does not automatically mean replacement is next: bracing, osteotomy and focal cartilage repair can reduce pain and delay arthroplasty when alignment and damage remain localised. Microfracture is now usually limited to very small defects, while AMIC, MACI, OATS and OCA are chosen by lesion size, depth and joint health.
Choosing Arthrosamid knee injections for osteoarthritisArthrosamid is a single ultrasound-guided hydrogel injection for mild-to-moderate knee osteoarthritis, used when exercise, painkillers and other non-surgical care have not eased function-limiting pain. Early studies show meaningful improvement for many patients at 12 months, but evidence remains less robust than for established treatments.Arthrosamid is a single ultrasound-guided hydrogel injection for mild-to-moderate knee osteoarthritis, used when exercise, painkillers and other non-surgical care have not eased function-limiting pain. Early studies show meaningful improvement for many patients at 12 months, but evidence remains less robust than for established treatments.
Choosing cartilage repair pathways for knee and ankleSmall focal cartilage defects in the knee and ankle are treated differently from diffuse arthritis: first with physiotherapy and symptom control, then with repair procedures such as microfracture for lesions under about 1.0 cm², scaffold augmentation for larger defects, and OATS or osteochondral allograft for bigger or cystic lesions.Small focal cartilage defects in the knee and ankle are treated differently from diffuse arthritis: first with physiotherapy and symptom control, then with repair procedures such as microfracture for lesions under about 1.0 cm², scaffold augmentation for larger defects, and OATS or osteochondral allograft for bigger or cystic lesions.
Which joint specialist to see and when to scanMost new non-traumatic joint and back pain settles within days to a few weeks and does not need immediate imaging or a specialist opinion. GP or community MSK physiotherapy is usually the first step, with same-day assessment reserved for trauma, a hot swollen joint, or back pain with bladder, bowel…Most new non-traumatic joint and back pain settles within days to a few weeks and does not need immediate imaging or a specialist opinion. GP or community MSK physiotherapy is usually the first step, with same-day assessment reserved for trauma, a hot swollen joint, or back pain with bladder, bowel or saddle numbness symptoms.
Choosing PRP or steroid injections for joint painPRP gives better medium-term pain and function relief than hyaluronic acid in some hip and knee osteoarthritis studies, while steroid injections work faster for inflammatory flares. Hip PRP has a smaller evidence base than knee PRP, and both treatments depend heavily on image-guided technique, preparation and patient selection.PRP gives better medium-term pain and function relief than hyaluronic acid in some hip and knee osteoarthritis studies, while steroid injections work faster for inflammatory flares. Hip PRP has a smaller evidence base than knee PRP, and both treatments depend heavily on image-guided technique, preparation and patient selection.
MACI knee surgery cost and insuranceMACI is a two-stage knee cartilage repair, so costs rise with the biopsy, lab cell expansion and later implantation rather than a single operation. In 2023, 89% of cases were approved on the first insurance submission, with approval typically taking 25–30 days.MACI is a two-stage knee cartilage repair, so costs rise with the biopsy, lab cell expansion and later implantation rather than a single operation. In 2023, 89% of cases were approved on the first insurance submission, with approval typically taking 25–30 days.
When to see a specialist for common sports injuriesMild sports injuries often start with self-management or a GP, physiotherapist or MSK clinician, but a locked or swollen knee, a shoulder that will not move properly, or a hamstring injury with a sudden pop, heavy bruising or weakness needs prompt specialist review. Function, not scan findings alone, should drive…Mild sports injuries often start with self-management or a GP, physiotherapist or MSK clinician, but a locked or swollen knee, a shoulder that will not move properly, or a hamstring injury with a sudden pop, heavy bruising or weakness needs prompt specialist review. Function, not scan findings alone, should drive urgency.
Choosing a ChondroFiller provider for knee defectsChondroFiller is most plausible for focal knee cartilage defects seen on MRI, not widespread arthritis, with outpatient injection packages from about £3,000 and arthroscopic Liquid Cartilage pathways from about £9,800. Good candidates are assessed for defect size, containment, location and any subchondral bone involvement, because those factors shape the treatment…ChondroFiller is most plausible for focal knee cartilage defects seen on MRI, not widespread arthritis, with outpatient injection packages from about £3,000 and arthroscopic Liquid Cartilage pathways from about £9,800. Good candidates are assessed for defect size, containment, location and any subchondral bone involvement, because those factors shape the treatment path.